Revolutionary Test for Detecting Drug-Induced Liver Injury Unveiled by C-Path’s Predictive Safety Testing Consortium
The Rise of Glutamate Dehydrogenase as a Liver-Specific Biomarker in Drug Development In the realm of drug development and clinical ...
